Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Regular cinnamon consumption may lower RA disease activity and symptoms, studies show. Learn how experts recommend getting your daily dose.

ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organisations ...

The European Alliance of Associations for Rheumatology – updated its recommendations on the treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARD). The 2025 update ...

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

A 55-year-old man developed painful swelling that doctors later thought was arthritis. Subtle clues revealed something more ...

The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

Abstract: This paper presents a novel high quality-factor (Q-factor) structure of a digitally tunable capacitor (DTC) for high RF power handling applications, such as reconfigurable power amplifiers ...